Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics
Cerebral Mechanism Involved in Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics (IIT)
Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
This PHASE4 trial investigates Schizophrenia and is currently completed. Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal leads this study, which shows 8 recorded versions since 2006 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Jul 2025 — Sep 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Sep 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
- Eli Lilly and Company
- Université de Montréal
For direct contact, visit the study record on ClinicalTrials.gov .